141 related articles for article (PubMed ID: 37896933)
21. Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: A cross-sectional study.
Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
J Clin Nurs; 2023 Jul; 32(13-14):3943-3953. PubMed ID: 36345133
[TBL] [Abstract][Full Text] [Related]
22. Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals.
Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi G; Lippi G
Clin Chem Lab Med; 2022 May; 60(6):930-933. PubMed ID: 35303764
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020-2 April 2022.
Cegolon L; Negro C; Pesce M; Filon FL
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851360
[No Abstract] [Full Text] [Related]
24. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose.
Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM
J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303
[TBL] [Abstract][Full Text] [Related]
25. The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers.
Biswas N; Mustapha T; Khubchandani J; Price JH
J Community Health; 2021 Dec; 46(6):1244-1251. PubMed ID: 33877534
[TBL] [Abstract][Full Text] [Related]
26. Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers.
Perez MJ; Paul R; Raghuraman N; Carter EB; Odibo AO; Kelly JC; Foeller ME
Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100557. PubMed ID: 34952227
[TBL] [Abstract][Full Text] [Related]
27. Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden.
Ljung R; Feychting M; Burström B; Möller J
Vaccine; 2022 May; 40(21):2904-2909. PubMed ID: 35428499
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
29. Evaluating primary and booster vaccination prioritization strategies for COVID-19 by age and high-contact employment status using data from contact surveys.
Roubenoff E; Feehan D; Mahmud AS
Epidemics; 2023 Jun; 43():100686. PubMed ID: 37167836
[TBL] [Abstract][Full Text] [Related]
30. Vaccination, time lost from work, and COVID-19 infections: a Canadian healthcare worker retrospective cohort study.
Okpani AI; Lockhart K; Grant JM; Barker S; Srigley JA; Yassi A
Front Public Health; 2023; 11():1214093. PubMed ID: 37608982
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
[TBL] [Abstract][Full Text] [Related]
32. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].
Kara E; Tanır F; Demirhindi H; Mete B; Kibar F; Çetiner S; Candevir A; İnaltekin A
Mikrobiyol Bul; 2022 Jul; 56(3):566-573. PubMed ID: 35960246
[TBL] [Abstract][Full Text] [Related]
33. Transition of Antibody Titers after SARS-CoV-2 mRNA Vaccination in Japanese Healthcare Workers.
Kitabatake M; Ouji-Sageshima N; Sonobe S; Furukawa R; Konda M; Hara A; Aoki H; Suzuki Y; Imakita N; Nakano A; Fujita Y; Shichino S; Nakano R; Ueha S; Kasahara K; Muro S; Yano H; Matsushima K; Ito T
Jpn J Infect Dis; 2023 Jan; 76(1):72-76. PubMed ID: 36047181
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
[TBL] [Abstract][Full Text] [Related]
35. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
Cegolon L; Negro C; Mastrangelo G; Filon FL;
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
[No Abstract] [Full Text] [Related]
36. Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study.
Veli N; Martin CA; Woolf K; Nazareth J; Pan D; Al-Oraibi A; Baggaley RF; Bryant L; Nellums LB; Gray LJ; Khunti K; Pareek M;
BMC Med; 2022 Oct; 20(1):386. PubMed ID: 36210437
[TBL] [Abstract][Full Text] [Related]
37. Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers.
Hasibuan AS; Koesnoe S; Widhani A; Muhadi M; Shatri H; Ginanjar E; Yunihastuti E; Soewondo P; Aman Nasution S; Djauzi S; Dina Liastuti L; Koento T; Sumariyono S; Mulyantini A
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851358
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers.
Oliver K; Raut A; Pierre S; Silvera L; Boulos A; Gale A; Baum A; Chory A; Davis NJ; D'Souza D; Freeman A; Goytia C; Hamilton A; Horowitz C; Islam N; Jeavons J; Knudsen J; Li S; Lupi J; Martin R; Maru S; Nabeel I; Pimenova D; Romanoff A; Rusanov S; Schwalbe NR; Vangeepuram N; Vreeman R; Masci J; Maru D
BMJ Open; 2022 Jan; 12(1):e053641. PubMed ID: 34992113
[TBL] [Abstract][Full Text] [Related]
39. Vaccinated Healthcare Workers' Adherence to COVID-19 Prevention Measures and Associated Factors in Northwest Ethiopia: A Facility-Based Cross-Sectional Study.
Gubae K; Agegnew Wondm S; Birhane W; Fetene A; Arega Moges T; Kiflu M
Risk Manag Healthc Policy; 2022; 15():2389-2398. PubMed ID: 36561728
[TBL] [Abstract][Full Text] [Related]
40. Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study.
Wen GP; Zhu M; Li LR; Li XJ; Ye HM; Zhou YL
Front Immunol; 2023; 14():1099629. PubMed ID: 36817474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
